Polaryx Therapeutics, Inc. - PLYX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$5.827M
QoQ value delta ($000)
-$11.31M
(-65.99%)
Implied price effect (QoQ)
-64.84%
Shares
Total shares
2,193,099
QoQ shares delta
-74,037
(-3.27%)
Total shares held by funds (by quarter)
Market chart (PLYX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4,409 | 1,657,872 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 455 | 170,998 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 279 | 105,072 | 0.0% |
| HRT FINANCIAL LP | 218 | 82,094 | 0.0% |
| STATE STREET CORP | 154 | 58,104 | 0.0% |
| BlackRock, Inc. | 109 | 41,012 | 0.0% |
| JANE STREET GROUP, LLC | 83 | 31,441 | 0.0% |
| NORTHERN TRUST CORP | 74 | 27,987 | 0.0% |
| Allworth Financial LP | 20 | 7,727 | 0.0% |
| Vanguard Global Advisers, LLC | 16 | 6,318 | 0.0% |
| Tower Research Capital LLC (TRC) | 7 | 3,002 | 0.0% |
| UBS Group AG | 3 | 1,283 | 0.0% |
| Fortitude Family Office, LLC | 0 | 189 | 0.0% |